Cancer Drug

<p>The 10th Circuit <strong><a href="http://www.courthousenews.com/wp-content/uploads/2020/05/cancerdrug.pdf">reversed</a></strong> a ruling in favor of biotech company Genentech in a dispute over the breast cancer drug Herceptin. Cancer treatment providers who purchased multi-dose vials of the drug claim the company failed to ensure each vial contained the labeled amount of the active ingredient. </p>

DENVER — The 10th Circuit reversed a ruling in favor of biotech company Genentech in a dispute over the breast cancer drug Herceptin. Cancer treatment providers who purchased multidose vials of the drug claim the company failed to ensure each vial contained the labeled amount of the active ingredient.

Categories / Appeals, Business, Health

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.